Prognostic properties of the baseline prostate-specific antigen value-insights from the European randomized study of screening for prostate cancer
Transl Androl Urol
.
2024 Mar 31;13(3):473-475.
doi: 10.21037/tau-23-606.
Epub 2024 Mar 11.
Authors
Thomas Paul Scherer
1
,
Cédric Poyet
1
Affiliation
1
Department of Urology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
PMID:
38590968
PMCID:
PMC10999015
DOI:
10.21037/tau-23-606
No abstract available
Keywords:
Screening; prostate cancer (PCa); prostate-specific antigen (PSA).
Publication types
Editorial
Comment